Overview
Updated 14 Jul 2026
David Alland, MD, is Professor and Chief, Division of Infectious Disease, Department of Medicine at Rutgers New Jersey Medical School. The public record shows 230 publications with 23,444 citations (h-index 68), centered on COVID-19. It also documents an investigator role on 1 registered clinical trials, 34 NIH-funded awards (2001–2026).
- Most recent indexed publication: 2026 · Journal of clinical microbiology
- Top research focus: COVID-19
- 1 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection
Sponsor: Rutgers, The State University of New Jersey
InvestigatorEarly phase 1CompletedNCT04931004
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 14 Jul 2026
34 NIH research awards on record, funded 2001–2026 per NIH RePORTER. The latest:
- Identifying drug tolerance mechanisms in Mycobacterium tuberculosis glpK mutants to develop better treatments against drug tolerant persister bacilli.
Rutgers Biomedical and Health Sciences
FY2026$811,772R01AI192623 - Unraveling the spectrum of intrabacterial amide hydrolysis to develop new classes of pyrazinoic acid prodrugs against pyrazinamide resistant Mycobacterium tuberculosis
Rutgers Biomedical and Health Sciences
FY2026$792,528R01AI189899 - Point of care detection of fluroquinolone, bedaquiline and linezolid resistant Mycobacterium tuberculosis for rapid treatment decisions.
Rutgers Biomedical and Health Sciences
FY2026$782,450R01AI182257
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A cartridge-based assay for improved detection of multidrug-resistant Mycobacterium tuberculosis directly from sputum.
Journal of clinical microbiology
2026 - The KasA inhibitor JSF-3285 improves the sterilizing activity of bedaquiline-pretomanid-containing regimens in a mouse model of tuberculosis.
Antimicrobial agents and chemotherapy
2025 - Identification of an antibiotic from an HTS targeting EF-Tu:tRNA interaction: a prospective topical treatment for MRSA skin infections.
Applied and environmental microbiology
2025
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
225 Warren Street, International Center for Public Health, Newark, NJ 07103
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
Editorial & leadership rolesjournal and society appointments
- Leads a group of 41 faculty and 145 research/support staff performing clinical care and research focused predominantly on tuberculosis and HIV
as Chief of the Division of Infectious Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms.rutgers.edu ↗
Awards & honorshonors on the public record
- 40th Annual Thomas Alva Edison Patent Award
Biotechnology category, for "Detection of Drug Resistant Mycobacterium Tuberculosis" (with Soumitesh Chakravorty), November 14
2019provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →njms.rutgers.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →njms.rutgers.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →njms.rutgers.edu ↗
Secondary affiliationsappointments beyond the home institution
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fend-tb.org ↗
- Director
Public Health Research Institute (PHRI), Rutgers New Jersey Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →phri.njms.rutgers.edu ↗ - Director
Center for Emerging Pathogens, Rutgers New Jersey Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →i3d.rutgers.edu ↗
Media & interviewspress, podcasts and appearances
- "Technology, Tests, & Teamwork: How a 22-year Collaboration Developed Cutting Edge Tests for TB & ID"
video feature on Alland's TB/ID diagnostics collaboration, October 2023
2023provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - "David Alland, PhD, on Finding a Cure for Drug-Resistant TB"
podcast interview on his tuberculosis research, AdHub360
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →adhub360.com ↗ - Featured speaker
HI-POCT'19 (High-Impact Point-of-Care Testing) conference
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hipt.embs.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- LinkedIn
linkedin.com/in/david-alland-915682207
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/David-Alland
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Doximity
doximity.com/pub/david-alland-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Facebook
facebook.com/photo.php
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/story.php
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/p/B-FoM2EpYu5
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.